<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font26 { font-size : 26; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font26">the </span>
   <span class="font18">with </span>
   <span class="font16">for </span>
   <span class="font15">will </span>
   <span class="font14">HSV </span>
   <span class="font13">are </span>
   <span class="font13">patients </span>
   <span class="font12">that </span>
   <span class="font12">The </span>
   <span class="font12">valacyclovir </span>
   <span class="font12">from </span>
   <span class="font11">treatment </span>
   <span class="font11">{background </span>
   <span class="font11">study </span>
   <span class="font11">antiviral </span>
   <span class="font11">simplex </span>
   <span class="font11">herpes </span>
   <span class="font11">not </span>
   <span class="font11">cognitive </span>
   <span class="font11">has </span>
   <span class="font11">margin </span>
   <span class="font11">PET </span>
   <span class="font11">amyloid </span>
   <span class="font11">brain </span>
   <span class="font11">virus </span>
   <span class="font11">{border-style </span>
   <span class="font11">Alzheimer's </span>
   <span class="font11">effect </span>
   <span class="font11">px;} </span>
   <span class="font11">trial </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Alzheimerâ€™s </span>
   <span class="font11">University </span>
   <span class="font11">between </span>
   <span class="font11">than </span>
   <span class="font11">weeks </span>
   <span class="font11">CSF </span>
   <span class="font11">acyclovir </span>
   <span class="font11">clinical </span>
   <span class="font11">size </span>
   <span class="font11">tau </span>
   <span class="font11">Institute </span>
   <span class="font11">dose </span>
   <span class="font11">levels </span>
   <span class="font11">mild </span>
   <span class="font10">MRI </span>
   <span class="font10">data </span>
   <span class="font10">may </span>
   <span class="font10">measures </span>
   <span class="font10">this </span>
   <span class="font10">Hypothesis </span>
   <span class="font10">disease </span>
   <span class="font10">viral </span>
   <span class="font10">AD. </span>
   <span class="font10">National </span>
   <span class="font10">been </span>
   <span class="font10">can </span>
   <span class="font10">impairment </span>
   <span class="font10">other </span>
   <span class="font10">phase </span>
   <span class="font10">test </span>
   <span class="font10">type </span>
   <span class="font10">ADAS-Cog </span>
   <span class="font10">HSV, </span>
   <span class="font10">Patients </span>
   <span class="font10">all </span>
   <span class="font10">cortical </span>
   <span class="font10">daily </span>
   <span class="font10">disease. </span>
   <span class="font10">infection </span>
   <span class="font10">placebo </span>
   <span class="font10">show </span>
   <span class="font10">was </span>
   <span class="font10">DNA </span>
   <span class="font10">Disease </span>
   <span class="font10">For </span>
   <span class="font10">baseline </span>
   <span class="font10">but </span>
   <span class="font10">during </span>
   <span class="font10">effects </span>
   <span class="font10">including </span>
   <span class="font10">outcome </span>
   <span class="font10">serum </span>
   <span class="font10">temporal </span>
   <span class="font10">Data </span>
   <span class="font10">F-Florbetapir </span>
   <span class="font10">Valacyclovir </span>
   <span class="font10">also </span>
   <span class="font10">consent </span>
   <span class="font10">double-blind, </span>
   <span class="font10">each </span>
   <span class="font10">have </span>
   <span class="font10">results </span>
   <span class="font10">their </span>
   <span class="font10">treated </span>
   <span class="font10">trial. </span>
   <span class="font10">two </span>
   <span class="font10">uptake </span>
   <span class="font10">who </span>
   <span class="font10">AD, </span>
   <span class="font10">Department </span>
   <span class="font10">ROIs </span>
   <span class="font10">YorkNew </span>
   <span class="font10">YorkUSA[], </span>
   <span class="font10">analysis </span>
   <span class="font10">antibodies </span>
   <span class="font10">apoE </span>
   <span class="font10">criteria </span>
   <span class="font10">decline </span>
   <span class="font10">efficacy </span>
   <span class="font10">grant </span>
   <span class="font10">major </span>
   <span class="font10">multiple </span>
   <span class="font10">oral </span>
   <span class="font10">over </span>
   <span class="font10">px; </span>
   <span class="font10">score </span>
   <span class="font10">sum </span>
   <span class="font10">used </span>
   <span class="font10">using </span>
   <span class="font10">{font-family </span>
   <span class="font10">Medical </span>
   <span class="font10">York </span>
   <span class="font10">after </span>
   <span class="font10">blood </span>
   <span class="font10">changes </span>
   <span class="font10">evidence </span>
   <span class="font10">font-size </span>
   <span class="font10">memory </span>
   <span class="font10">more </span>
   <span class="font10">randomised, </span>
   <span class="font10">safety </span>
   <span class="font10">scan </span>
   <span class="font10">seropositivity </span>
   <span class="font10">study. </span>
   <span class="font10">superior </span>
   <span class="font10">these </span>
   <span class="font10">which </span>
   <span class="font10">-week </span>
   <span class="font10">Centre </span>
   <span class="font10">Change </span>
   <span class="font10">Clinical </span>
   <span class="font10">III </span>
   <span class="font10">assessment </span>
   <span class="font10">based </span>
   <span class="font10">because </span>
   <span class="font10">change </span>
   <span class="font10">deficits </span>
   <span class="font10">detectable </span>
   <span class="font10">disease: </span>
   <span class="font10">double; </span>
   <span class="font10">estimated </span>
   <span class="font10">exposure </span>
   <span class="font10">group </span>
   <span class="font10">increased </span>
   <span class="font10">individuals </span>
   <span class="font10">its </span>
   <span class="font10">lead </span>
   <span class="font10">less </span>
   <span class="font10">medial </span>
   <span class="font10">medications </span>
   <span class="font10">older </span>
   <span class="font10">out </span>
   <span class="font10">per </span>
   <span class="font10">positive </span>
   <span class="font10">prior </span>
   <span class="font10">reduce </span>
   <span class="font10">risk </span>
   <span class="font10">scans </span>
   <span class="font10">scores </span>
   <span class="font10">support </span>
   <span class="font10">trials </span>
   <span class="font10">use </span>
   <span class="font10">without </span>
   <span class="font10">Aging </span>
   <span class="font10">Alzheimer </span>
   <span class="font10">Alzheimers </span>
   <span class="font10">Columbia </span>
   <span class="font10">New </span>
   <span class="font10">Pennsylvania </span>
   <span class="font10">State </span>
   <span class="font10">This </span>
   <span class="font10">Treatment </span>
   <span class="font10">adults </span>
   <span class="font10">any </span>
   <span class="font10">association </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">cause </span>
   <span class="font10">cerebrospinal </span>
   <span class="font10">cognition </span>
   <span class="font10">compared </span>
   <span class="font10">conducted </span>
   <span class="font10">dementia </span>
   <span class="font10">diagnosis </span>
   <span class="font10">due </span>
   <span class="font10">effects. </span>
   <span class="font10">emission </span>
   <span class="font10">examine </span>
   <span class="font10">exploratory </span>
   <span class="font10">imaging </span>
   <span class="font10">increase </span>
   <span class="font10">inferior </span>
   <span class="font10">measure </span>
   <span class="font10">neurological </span>
   <span class="font10">new </span>
   <span class="font10">patient </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">plaques </span>
   <span class="font10">positron </span>
   <span class="font10">primary </span>
   <span class="font10">protocol </span>
   <span class="font10">range </span>
   <span class="font10">research </span>
   <span class="font10">sample </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">tests </span>
   <span class="font10">there </span>
   <span class="font10">time-points </span>
   <span class="font10">valacyclovir, </span>
   <span class="font10">via </span>
   <span class="font10">viruses </span>
   <span class="font10">weeks, </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(Hypothesis </span>
   <span class="font10">ADCS-ADL </span>
   <span class="font10">Cognitive </span>
   <span class="font10">F-MK- </span>
   <span class="font10">HSV. </span>
   <span class="font10">IgG </span>
   <span class="font10">Mental </span>
   <span class="font10">Patient </span>
   <span class="font10">Psychiatric </span>
   <span class="font10">Research </span>
   <span class="font10">Safety </span>
   <span class="font10">Statistical </span>
   <span class="font10">These </span>
   <span class="font10">UPSIT </span>
   <span class="font10">acute </span>
   <span class="font10">against </span>
   <span class="font10">analyses </span>
   <span class="font10">antibody </span>
   <span class="font10">being </span>
   <span class="font10">bold </span>
   <span class="font10">cingulate, </span>
   <span class="font10">common </span>
   <span class="font10">conduct </span>
   <span class="font10">consultant </span>
   <span class="font10">control </span>
   <span class="font10">courier; </span>
   <span class="font10">daily. </span>
   <span class="font10">dementia, </span>
   <span class="font10">dementia. </span>
   <span class="font10">drug </span>
   <span class="font10">duration </span>
   <span class="font10">either </span>
   <span class="font10">em; </span>
   <span class="font10">evaluate </span>
   <span class="font10">fluid </span>
   <span class="font10">followed </span>
   <span class="font10">function </span>
   <span class="font10">genotype </span>
   <span class="font10">gyrus, </span>
   <span class="font10">include </span>
   <span class="font10">includes </span>
   <span class="font10">into </span>
   <span class="font10">is, </span>
   <span class="font10">latent </span>
   <span class="font10">linear </span>
   <span class="font10">main </span>
   <span class="font10">months </span>
   <span class="font10">obtain </span>
   <span class="font10">obtained </span>
   <span class="font10">occur </span>
   <span class="font10">olfactory </span>
   <span class="font10">one </span>
   <span class="font10">outcomes, </span>
   <span class="font10">placebo) </span>
   <span class="font10">placebo-controlled, </span>
   <span class="font10">placebo. </span>
   <span class="font10">power </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">random </span>
   <span class="font10">randomisation </span>
   <span class="font10">relationship </span>
   <span class="font10">respectively. </span>
   <span class="font10">results. </span>
   <span class="font10">shown </span>
   <span class="font10">significance </span>
   <span class="font10">significant </span>
   <span class="font10">six </span>
   <span class="font10">specific </span>
   <span class="font10">subject </span>
   <span class="font10">system </span>
   <span class="font10">tested </span>
   <span class="font10">then </span>
   <span class="font10">total </span>
   <span class="font10">weeks), </span>
   <span class="font10">years </span>
   <span class="font10">â€‰mg </span>
   <span class="font10">â€“â€‰g </span>
  </p>
 </body>
</html>
